NVAX Financial Facts

General and administrative: 5.81M
Net loss: -17.86M
See Full Income Statement

Total assets: 311.99M
Total liabilities and stockholders' equity: 311.99M
See Full Balance Sheet

Novavax, Inc. (NVAX) Earnings

  |   Expand Research on NVAX
Next EPS Date N/A EPS Growth Rate -20.0%
Average EPS % Beat Rate -8.8% Revenue Growth Rate -21.4%
Average % Move 1-Wk after EPS -2.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/10/14 Q413 -$0.07-$0.08 +$0.01$8.75M$6.22M N/A Details
11/7/13 Q313 N/A-$0.06 N/A N/A$4.56M N/A N/A N/A
8/6/14 Q214 -$0.08-$0.07 -$0.01$8.26M$8.74M N/A Details
5/7/14 Q114 -$0.07-$0.07 $0.00$7.5M$3.8M N/A Details
8/8/13 Q213 -$0.08-$0.06 -$0.02$3.52M$4.45M N/A Details
3/28/11 Q410 -$0.06-$0.09 +$0.03$51K$110K N/A Details
11/5/10 Q310 -$0.10-$0.09 -$0.01N/AN/A N/A Details
5/9/11 Q111 -$0.07-$0.07 $0.00$834K$2.29M N/A Details